Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/1999

01-06-1999

Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal

Authors: M. Federico, A. Maiorana, L. Mangone, D. Turchetti, B. Canossi, L. Cortesi, R. Romagnoli, V. Silingardi

Published in: Breast Cancer Research and Treatment | Issue 3/1999

Login to get access
Metadata
Title
Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal
Authors
M. Federico
A. Maiorana
L. Mangone
D. Turchetti
B. Canossi
L. Cortesi
R. Romagnoli
V. Silingardi
Publication date
01-06-1999
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 3/1999
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1006192230332

Other articles of this Issue 3/1999

Breast Cancer Research and Treatment 3/1999 Go to the issue

OriginalPaper

Letter to the Editor

OriginalPaper

Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony‐stimulating factor

OriginalPaper

Author Index, Volume 55

OriginalPaper

A study on the cost effectiveness of sestamibi scintimammography for screening women with dense breasts for breast cancer

OriginalPaper

Early age at menopause and breast cancer: are leaner women more protected? A prospective analysis of the Dutch DOM cohort

OriginalPaper

Breast cancer and timing of surgery during menstrual cycle: a 5‐year analysis of 248 premenopausal women
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits